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AbstrAct
Introduction  Arthroscopic surgery is a very common 
orthopaedic procedure. While several trials have 
investigated the effect of knee arthroscopy for middle-
aged and older patients with meniscal tears, there is a 
paucity of trials comparing meniscal surgery with non-
surgical treatment for younger adults. The aim of this 
randomised controlled trial (RCT) is to investigate if early 
arthroscopic surgery is superior to exercise therapy and 
education, with the option of later surgery if needed, in 
improving pain, function and quality of life in younger 
adults with meniscal tears.
Methods and analysis  This is a protocol for a multicentre, 
parallel-group RCT conducted at six hospitals across all five 
healthcare regions in Denmark. 140 patients aged 18–40 
years with a clinical history and symptoms consistent with 
a meniscal tear, verified on MRI, found eligible for meniscal 
surgery by an orthopaedic surgeon will be randomly allocated 
to one of two groups (1:1 ratio). Participants randomised 
to surgery will undergo either arthroscopic partial 
meniscectomy or meniscal repair followed by standard 
postsurgical care, while participants allocated to exercise and 
education will undergo a 12-week individualised, supervised 
neuromuscular and strengthening exercise programme and 
patient education. The primary outcome will be difference 
in change from baseline to 12 months in the mean score on 
four Knee Injury and Osteoarthritis Outcome Score subscales, 
covering pain, symptoms, function in sports and recreation 
and quality of life (Knee Injury and Osteoarthritis Outcome 
Score (KOOS
4)) supported by the individual subscale scores 
allowing clinical interpretation. Alongside, the RCT an 
observational cohort will follow patients aged 18–40 years 
with clinical suspicion of a meniscal tear, but not fully eligible 
or declining to participate in the trial.
Ethics and dissemination  Results will be presented in 
peer-reviewed journals and at international conferences. 
This study is approved by the Regional Committees on 
Health Research Ethics for Southern Denmark.
registration details   ClinicalTrials. gov (NCT02995551).
bAckground
Knee arthroscopy is a very commonly performed 
orthopaedic procedure.1 2 According to 
the previous reports, around 1 million proce-
dures are performed annually in the USA3 
and 150 000 procedures in the UK,4 with most 
procedures involving meniscal tears.3 4
Systematic reviews and meta-analyses of 
randomised trials show no better effect of 
arthroscopic partial meniscectomy (APM) for 
middle-aged and older patients with degen-
erative meniscal tears compared with placebo 
surgery or in addition to exercise.5 6 In addi-
tion, meniscal surgery is associated with risk 
of adverse events.5 A recent randomised 
controlled trial (RCT) confirmed that exer-
cise therapy is a valid treatment option for 
middle-aged patients with degenerative 
meniscal tears as no difference was observed in 
patient-reported outcomes, when comparing 
APM surgery with exercise therapy head-to-
head.7 However, no RCTs have compared 
arthroscopic meniscal surgery for patients 
aged 40 years or younger with non-surgical 
treatments.8
In contrast to middle-aged and older 
people with degenerative meniscal tears 
most tears in younger adults are of traumatic 
origin from a work-related or sports-related 
trauma.9 Symptoms associated with meniscal 
tears are considered to be resolved with 
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Protocol
strengths and limitations of this study
 ► This study addresses an important evidence gap 
regarding the optimal treatment strategy of meniscal 
tears in young adults.
 ► The multicentre design including patients from all 
healthcare regions of Denmark comparing two 
feasible and clinically relevant treatment strategies 
will support external validity and implementation.
 ► Owing to the type of interventions, blinding of the 
patients and treatment providers is not possible.
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Figure 1 Patient flow through the study. RCT, randomised 
controlled trial; KOOS4, the mean score for the Knee 
Injury and Osteoarthritis Outcome Score subscales pain, 
symptoms, function in sports and recreational activities 
(Sport/Rec) and quality of life (QOL). 
surgery (ie, repair or resection), but exercise might be 
a valid treatment option considering previous trials in 
middle-aged and older patients.5 7 Evidence from more 
severe traumatic knee injuries such as anterior cruciate 
ligament (ACL) tears suggest that more than half of 
ACL-injured patients can obtain satisfactory knee func-
tion with structured and supervised exercise therapy as 
first-line treatment before considering surgery.10
The aim of this RCT is to investigate if early arthroscopic 
meniscal surgery is superior to individualised supervised 
exercise therapy and patient education, with the option 
of later surgery if needed, in improving pain, function 
and quality of life in young patients (18–40 years of 
age) with meniscal tears. We hypothesise that patients 
randomised to surgery will improve significantly more in 
pain, function and quality of life after 12 months than 
those randomised to exercise and patient education.
MEthods And AnAlysIs
Study design
This study protocol (version 2, 30 March 2017) describe 
the design of a multicentre, parallel-group RCT (1:1 
ratio) conducted at six orthopaedic departments across 
all five healthcare regions in Denmark.
The study protocol conforms with the Standard 
Protocol Items: Recommendations for Interventional 
Trials (SPIRIT)11 while the RCT will conform to the 
Consolidated Standards of Reporting Trials (CONSORT) 
statement for reporting RCTs.12
The orthopaedic departments at Aalborg University 
Hospital, Aarhus University Hospital, Lillebælt Hospital 
(Kolding), Næstved Hospital and Copenhagen University 
Hospital (Amager-Hvidovre) will recruit patients for the 
study.
The study is registered at  ClinicalTrials. gov in December 
2016 (NCT02995551) and enrolment started at the first 
hospital in January 2017 and at the last hospital in April 
2017 and recruitment is expected to finalise in June 2018.
Patients
One hundred and forty patients fulfilling the eligibility 
criteria below will be included.
Inclusion criteria
 ► Adults aged 18–40 years with knee pain.
 ► Clinical history and symptoms consistent with menis-
cal tear and meniscal tear verified on MRI.
 ► Deemed eligible for meniscal surgery (ie, repair or re-
section) by the examining orthopaedic surgeon.
 ► Willing to participate in 12 weeks of supervised exer-
cise twice a week and undergo surgery for the menis-
cal tear as soon as possible.
Exclusion criteria
 ► Previous knee surgery on the affected knee.
 ► Clinical suspicion (acute locking of knee and/or ex-
tension deficit) of displaced bucket-handle tear con-
firmed by MRI.
 ► Fracture of the affected extremity within the previous 
6 months.
 ► Complete rupture of one or more knee ligaments.
 ► Participation in supervised systematic exercise for 
knee problems within the last 3 months prior to re-
cruitment.
 ► Other reasons for exclusion (unable to understand 
Danish, mentally unable to participate, etc).
Recruitment procedure
The overall trial flow is outlined in figure 1. Patients 
referred to the orthopaedic department at one of the six 
hospitals and complying with the eligibility criteria will 
be invited to participate in the RCT study. Orthopaedic 
surgeons, nurses and physiotherapists involved in recruit-
ment have been trained and instructed in the recruitment 
procedure in order to maximise the recruitment rate.
Oral and written information about the study will be 
provided by the examining orthopaedic surgeon and/or 
by a nurse or physiotherapist at the six different recruiting 
orthopaedic departments in an undisturbed room during 
consultation at the hospital. The study information is 
also available in a video for the patient to watch at home 
or at the hospital, before deciding to participate or not. 
Patients are recommended to take at least 24 hours to 
consider and discuss participation with a relative or a lay 
representative before deciding on participation in the 
study.
Either the local project worker or a central study coor-
dinator (depending on local differences at the hospitals) 
will contact the patient and ask whether they are willing 
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to participate in the study. If so, written informed consent 
will be obtained (see online supplementary file 1).
randomisation procedure and concealment of allocation
Patients fulfilling eligibility criteria and willing to partic-
ipate will be randomised after baseline assessment (1:1 
allocation ratio). A priori, an independent statistician has 
prepared a computer-generated randomisation schedule 
in random-sized permuted blocks of four or six patients 
stratified by hospital and gender to ensure that the 
number of participants receiving the two interventions 
is closely balanced within each stratum. The allocation 
numbers will be concealed in opaque sealed envelopes 
prepared by a central study coordinator. The envelopes 
will only be accessible by the central study coordinator, 
only opening them after informed consent and baseline 
measures have been obtained.
blinding
An independent statistician blinded to group allocation 
will perform the primary RCT analysis. To reduce risk 
of interpretation bias, blinded results from the analyses 
(Group A compared with Group B) will be presented 
to all authors, who will agree on two alternative written 
interpretations before the data manager unblinds the 
randomisation code.13
observational cohort
Patients fulfilling all eligibility criteria, but unwilling to 
participate in the randomised study, and patients aged 
18–40 years with a clinical history and symptoms consis-
tent with a meniscal tear, but not fulfilling the other 
eligibility criteria, are invited into an observational cohort 
with the same self-reported questionnaires as applied in 
the RCT, but following usual clinical practice. Written 
informed consent will be obtained for all cohort partic-
ipants.
Interventions
Patients will be randomised to one of two treatments initi-
ated as soon as possible after randomisation.
Arthroscopic meniscal surgery
Arthroscopic meniscal repair or resection will be 
conducted at the discretion of the operating surgeon at 
one of the six hospitals. The specific surgical procedure 
(ie, repair or resection) cannot be determined before 
the surgeon has visual confirmation about the exact knee 
pathology and extent of the meniscal tear at arthroscopy. 
Patients will receive the standard postoperative reha-
bilitation depending on type of surgery (ie, repair or 
resection). A standard leaflet with exercises will be given 
to patients undergoing APM at all surgery sites. Patients 
undergoing meniscal repair will follow a hospital-specific 
rehabilitation regimen to improve the external validity of 
the study findings. The hospital-specific regimes range 
from postsurgical control of range of motion and instruc-
tion in a standardised postsurgical exercise programme 
to referral to supervised, knee-related exercises focusing 
on increasing range of motion and strength, most often 
in patients with reduced range of motion or not able to 
activate vastus medialis following meniscal repair.
Exercise therapy and patient education
Patients allocated to exercise therapy and patient 
education will twice weekly participate in a 12-week 
individualised, supervised exercise programme (approx-
imately 60–90 min/session) tailored to 18–40 years old 
patients with meniscal tear. The content of the exercise 
therapy programme was guided by available evidence 
from patients with other types of knee injuries and osteo-
arthritis7 10 14–17 and developed in close collaboration with 
experienced physical therapists and pilot patients.18 Each 
exercise session includes a warm up period of 5 min on 
a stationary bike and neuromuscular and strengthening 
exercises focusing on the lower extremities. If needed 
during the first weeks, two exercises focusing on reducing 
swelling and increasing range of motion is included. The 
neuromuscular exercises are individualised based on 
2–6 levels of difficulty and performed with 10–15 repeti-
tions in 2–3 sets. The strengthening exercises are initially 
performed in two sets of 15 repetitions, progressing to 
three sets of 12, three sets of 10 and three sets of eight 
repetitions.18 The exercise therapy programme was 
tested in a pilot study18 and reported according to the 
Consensus on Exercise Reporting Template (CERT).19 
The pilot study included six patients fulfilling the same 
eligibility criteria as for the present RCT. The exercise 
programme was found feasible with few short-lasting 
periods of increased pain or other symptoms during the 
exercises and marked self-reported improvements after 
12 weeks.18 For full details about the exercise programme 
please refer to Skou and Thorlund.18
The patient education was developed to support the 
exercise therapy programme and build motivation 
and capability to sustain the exercise after the 12-week 
programme. It was adapted, through interviews with 
pilot study participants, based on our experiences from 
the Good Life with osteoArthritis in Denmark (GLA:D) 
programme for patients with knee and hip pain.17 See 
further description in table 1 according to the Template 
for Intervention Description and Replication (TIDieR).20
The exercise therapy programme and patient educa-
tion will be delivered at one of 16 private physiotherapy 
clinics and municipalities geographically related to the 
six hospitals. All physiotherapists are part of the GLA:D 
infrastructure and used to deliver and supervise exer-
cise therapy in a similar manner as in the present study. 
Furthermore, all physiotherapists attended a specific 
half-day course to be certified to deliver the specific treat-
ment in this trial.
Crossover and discontinuation
Crossovers are common in studies randomising patients 
to surgical or non-surgical treatment.10 14 21 Based on 
previous experience, a number of precautions have been 
taken to reduce crossover and discontinuation. Within 
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Table 1 Overview of the patient education*
Item Description
1. Brief name DREAM patient education
2. Why The education programme was adapted through interviews with pilot study participants 
from our experiences from the GLA:D programme for patients with knee and hip pain.17 The 
programme will support the exercise therapy programme and build motivation and capability 
to sustain the exercise after the 12-week programme.
3. What materials A Power Point presentation supported by a manual for physiotherapists describing what to 
say and how to respond to specific queries.
4. What procedures In the initial phase of the 12-week programme, the patients will be given information on 
meniscal tears, symptoms, treatments and prognosis and focus on individual goals. At the 
end of the 12 weeks, a session focusing on sustaining the motivation for continuous exercise, 
return to sports and other activities and future goals will be given.
5. Who provided The education will be delivered by the physiotherapists supervising the exercise programme. 
The physiotherapists have all undergone training in the GLA:D programme and study-specific 
training.
6. How Delivered face to face in groups and individually.
7. Where At private physiotherapy clinics and municipalities across Denmark.
8. When and how much In the beginning and at the end of the 12-week programme in two or more sessions. 
Total duration is expected to be 30–45 min. During the exercise, programme patients and 
physiotherapists will discuss subjects related to the education and individual patient goals.
9. Tailoring The patients will set individual goals that will be followed up after the 12-week programme.
10. Modifications Modifications will be reported (if any).
11. How well (planned) The physiotherapists have received training before the study was initiated in how to deliver 
and supervise the education and exercise therapy programme.
12. How well (actual) This will be reported in the primary paper.
*Described according to the Template for Intervention Description and Replication (TIDieR).20
DREAM, Danish Rct on Exercise versus Arthroscopic Meniscal surgery for young adults; GLA:D, Good Life with osteoArthritis in Denmark.
1 week from randomisation, the central study coordi-
nator will call patients and talk to them about their 
participation in the study and what is going to happen 
during the study. The physiotherapists have been trained 
to encourage patients to stay in the exercise and educa-
tion group at least until after the 12-week programme 
has been completed. This is important as it often require 
around 6 weeks before important improvements in pain 
are reported.22 Results from the pilot study suggest that 
clinically important improvements might not occur until 
after 8–10 weeks.18 A similar time frame of improve-
ments can be expected for patients undergoing surgery. 
Patients insisting to crossover to surgery or discontinue 
their participation will be contacted by the central study 
coordinator regarding their reasons for crossover or 
discontinuation. If needed, they will be reassessed by an 
orthopaedic surgeon. The reason for each crossover and 
discontinuations will be registered. Patients crossing over 
will remain in the study and will be included in the inten-
tion-to-treat analyses.
The general crossover criteria from exercise and educa-
tion to surgery are:
 ► score of 25 or less on the pain and/or quality of life 
(QOL) subscale on the Knee Injury and Osteoarthri-
tis Outcome Score (KOOS)23 24 or,
 ► agreement between patient and orthopaedic surgeon 
that surgery is necessary.
Data collection procedure
Data will be collected at baseline, at surgery (for those 
randomised to surgery) and 3, 6 and 12 months after 
initiating the treatment. All but the physical performance 
tests will be collected using online-based questionnaires 
or Short Message Services (SMS). Physical performance 
measures will be assessed at the hospitals by project 
workers specifically trained in the test protocol. Please 
refer to table 2 for an overview of collection of the 
different outcomes.
outcomes
Baseline characteristics
Patient characteristics such as height, weight, pain loca-
tion, symptom duration and symptom onset will be 
collected. Symptom duration and symptom onset will 
be answered by the questions: ‘How long have you had 
your knee pain/problems for which you are now having 
treatment?’ with six response options ranging from ‘less 
than 2 weeks’ to ‘more than 24 months’, ‘How did the 
knee pain/problems for which you are now having treat-
ment develop?’ with three response options ‘The pain/
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Table 2 Overview of data collection*
Baseline Surgery 3 month 6 month 12 month
Baseline characteristics
Age X
Gender X
Study knee X
Height X
Weight X X X X
Education level X
Employment status X
Prior treatment of knee X
Smoking status X
Comorbidities X
Symptom duration X
Symptom onset X
Joint line tenderness (medial 
and lateral)
X
Thessaly’s test (at 20° knee 
flexion)
X
McMurray’s test X
Surgery information
ISAKOS meniscal tear 
classification
X
Surgery reports X
Patient reported outcomes
KOOS X X X X
WOMET X X X X
EQ-5D X X X X
Physical activity level X X X X
Sports participation X X X X
Pain location X X X X
Symptoms of catching and 
locking
X X X X
Knee instability X X X X
Global perceived effect X X X
Patient acceptable symptom 
state
X X X
Treatment failure X
Physical performance tests
Isometric muscle strength X X X
Knee-bend test X X X
Jump performance (two tests) X
Adverse events
Patient-reported at follow-up X X X
Medical record review X
Treatment-related variables
Continued
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Baseline Surgery 3 month 6 month 12 month
Compliance with and 
progression of exercise (only for 
patients in the exercise group, 
registered after each session)
X
Participation in postsurgery 
exercise (only for patients in the 
surgery group)
X
Surgery and/or other treatments 
during follow-up
X
*Some of the other outcome measures will be collected using Short Message Services and are not shown as they follow a different follow-up 
pattern.
Data in the surgery column are only collected for patients undergoing surgery.
EQ-5D, EuroQol Group 5-Dimension Self-Report Questionnaire; ISAKOS, International Society of Arthroscopy, Knee Surgery and Orthopaedic 
Sports Medicine, classification of meniscal tears questionnaire; KOOS, Knee injury and Osteoarthritis Outcome Score; WOMET, Western 
Ontario Meniscal Evaluation Tool.
Table 2 Continued 
problems have slowly developed over time’, ‘As a result 
of a less severe incident (ie, kneeling, sliding, and/or 
twisting of the knee or the like)’, and ‘As a result of a 
severe incident (ie, during sports, a crash, or a collision 
or the like)’.
Primary outcome
The primary outcome will be the between-group differ-
ence in change in KOOS4 between the group randomised 
to meniscal surgery and the group randomised to exer-
cise therapy and patient education from baseline to 
12 months follow-up. KOOS4 is the mean score for the 
KOOS subscales pain, symptoms, function in sports and 
recreational activities (Sport/Rec) and quality of life 
(QOL); the same score was used in a trial comparing 
surgery to supervised exercise as treatment for ACL tears 
in patients of similar age as in the present trial.10 KOOS 
subscale scores range from 0 (worst) to 100 (best).23 24 
KOOS is a validated knee-specific questionnaire used to 
assess patient-reported outcomes in the continuum from 
knee injury (including meniscal tears) to osteoarthritis 
and is widely used across the world.23–25
Secondary outcomes
KOOS subscales
To allow for clinical in-depth interpretation, the primary 
outcome will be complemented by the five individual 
KOOS subscales (ie, including the fifth subscale—activ-
ities of daily living (ADL) subscale).23 24
Western Ontario Meniscal Evaluation Tool (WOMET)
WOMET26 27 is a meniscus specific valid, reliable and 
responsive patient-reported outcome measure that will 
be used to complement the KOOS score.
Physical performance
Isometric muscle strength will be assessed using the 
reliable and valid FysioMeter,28 functional performance 
measured using the maximum number of knee-bends in 
30 s, the one-leg hop for distance and the 6 m timed hop 
previously applied in trials comparing meniscal surgery 
to exercise.7 The two hop tests will only be assessed at 12 
months due to risk of re-injury.
Adverse events
Adverse events (AE) and serious adverse events (SAE) 
will be recorded at all follow-ups by asking patients about 
potential AEs using open-probe questioning to ensure that 
all AEs are recorded. Furthermore, the medical records 
from the participating hospitals will be checked at the 
primary endpoint (12 months) for all AEs occurring from 
inclusion until the 12 months follow-up. An AE is defined 
as any undesirable experience during follow-up leading to 
contact with the healthcare system (general practitioner 
or hospital). If an AE result in hospitalisation, prolonged 
inpatient hospital care, result in re-surgery, or if an AE 
is life-threatening, result in death, permanent disability 
or damage, they will be categorised as SAEs.29 SAE will 
include cardiovascular or gastrointestinal events, pulmo-
nary embolism, systemic or local infection (or treatment 
with antibiotics) and deep vein thrombosis, but also other 
AEs adhering to the definition above will be categorised 
as an SAE. Crossover to surgery will not be considered as 
an adverse event as the study is comparing two treatment 
strategies: early surgery or early exercise and education 
with the possibility of later surgery. However, crossover to 
surgery will be registered and reported as it is important 
when evaluating the clinical applicability of the results. 
AEs will be categorised into index knee or other sites and 
will be recorded and assessed for severity by the adjudica-
tion committee independent of whether or not there is a 
causal relationship with study treatments. For all AEs, date 
of healthcare system contact will be registered. Further-
more, duration of SAEs and potential consequences of 
SAEs will be assessed.
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Other outcomes measures
EQ-5D-5L
General health will be assessed using the reliable and 
valid EQ-5D-5L questionnaire (5-level version), both the 
descriptive index and the EQ-VAS.30 31 This will also allow 
for a later cost-effectiveness analysis.
Physical activity and sports
Information on physical activity level32 and participation 
in sports (Tegner activity scale)33 will be collected.
Pain location
Patients are asked about pain in other body parts than 
the knee during the last week with the categories: foot or 
lower leg, thigh and hip, back, neck or shoulders and arm 
or hand, all answered by ‘yes’ or ‘no’.
Symptoms of catching and locking
Patients will report the presence and frequency of 
mechanical knee symptoms (ie, the sensation of catching 
and locking) based on the question: ‘How often have 
you experienced catching or locking of the knee that is 
about to undergo treatment?’ with five response options 
ranging from ‘never’ to ‘daily’.
Knee instability
Patients will report the presence and frequency of knee 
instability based on the question: ‘In the last month, 
have you felt that your knee was unstable or was about to 
buckle’ with six response options ranging from ‘never’ to 
‘all the time’. Subsequently, the patients are asked to what 
extent the knee instability have affected their daily activity 
level in the last month answered by one of six response 
options ranging from ‘my knee is not unstable or about to 
buckle’ to ‘the symptoms keeps me away from all activities 
of daily living’.
Global perceived effect, patient acceptable symptom state and 
treatment failure
Global perceived effect (GPE) will be assessed with the 
question: How are your knee problems now compared 
with before you entered this study? Answered on a seven-
point Likert scale ranging from ‘Improved, an important 
improvement’ to ‘Worse, an important worsening’. Satis-
faction with current knee function (ie, patient acceptable 
symptom state (PASS)) will be assessed with the question: 
“When you think of your knee function, will you consider 
your current condition as satisfying? By knee function, you 
should take into account your activities of daily living, 
sport and recreational activities, your pain and other 
symptoms and your quality of life’. Answered by ‘yes’ 
or ‘no’. This question has previously been used to assess 
PASS34 in patients with knee injury.35 Participants not 
satisfied with current knee function (ie, answering ‘no’ 
to the PASS question) will be asked to complete a second 
single-item question, relating to treatment failure (TF) 
at the 12-month follow-up: ‘Would you consider your 
current state as being so unsatisfactory that you think the 
treatment has failed?’. Answered by ‘yes’ or ‘no’.35
Pain and function during follow-up
Using SMS, all patients in the RCT will receive a ques-
tionnaire each week during the first 3 months and after 
that each month until the 12 months follow-up with ques-
tions from the subscale Sport/Rec from the KOOS23 24 
and a question regarding pain intensity when ascending/
descending stairs and a question regarding pain intensity 
during sitting/lying on a 11-point Numeric Rating Scale 
(NRS).36 Patients in the observational cohort will only 
receive the SMS monthly until the 12 months follow-up. 
Patients in the group randomised to exercise and educa-
tion will, in addition, register pain intensity on a 11-point 
NRS36 before and after each of the supervised exercise 
sessions.
Treatment-related outcomes
Information on knee pathology and type of surgery
Information about location of tear, type of tear and type of 
treatment (repair or resection) will be collected using an 
expanded version of the International Society of Arthros-
copy, Knee Surgery and Orthopaedic Sports Medicine 
(ISAKOS) classification of meniscal tears questionnaire 
by the operating surgeon,37 including International Carti-
lage Repair Society (ICRS) grading of cartilage damage.38 
This will be supplemented with data from surgery reports 
on specific pathological findings and surgical procedures 
carried out.
Compliance, exercise level/intensity and other treatments received 
during the study
Compliance with the supervised exercise sessions (ie, 
number of sessions out of 24 possible sessions) and 
progression of the exercises will be registered for patients 
in the group randomised to exercise and education. 
Poor compliance is defined as participating in less than 
18 of the 24 exercise sessions. Any participation in super-
vised exercise postsurgery will be self-reported using an 
online questionnaire in the group randomised to surgery. 
Surgery of the knee during follow-up will be registered 
through a review of the medical records.
Furthermore, patients will be asked to report other 
treatments related to the knee that they received during 
follow-up.
data management
The data collection and management procedures have 
been approved by the Danish Data Protection Agency 
(University of Southern Denmark, 16/45314). Personal 
information about patients will be kept separate from the 
main dataset and will not be shared. All personal data 
will be stored securely in order to protect confidentiality 
before, during and after the trial. Data entry and coding 
of the de-identified data will be conducted by trained staff 
at the University of Southern Denmark.
data monitoring
The study will not have a formal data monitoring 
committee as adverse events of treatments are well known 
due to their wide application in the healthcare sector. 
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Any unexpected serious adverse events or outcomes will 
be discussed by the trial management committee (iden-
tical to the authors of this protocol). Furthermore, the 
trial management committee will monitor recruitment, 
treatment and attrition rates and any concerns related to 
the study.
Adjudication committee
An adjudication committee, comprising members with 
prior adjudication experience, will independently adju-
dicate all adverse events in the RCT as to whether they 
are serious adverse events or not and categorise them 
into subcategories. They will each receive the adverse 
events in raw format after the last patient has undergone 
the 12 month follow-up. Any disagreements between the 
adjudication committee members will be resolved by 
consensus. If consensus cannot be reached, additional 
information will be requested from the hospitals.
sample size calculation
The study will be powered to detect a difference in 
change of 10 points between the surgical and non-sur-
gical group in the primary outcome (KOOS4) from 
baseline to 12 months follow-up. A 10-point difference in 
change between groups in KOOS4 is considered clinically 
relevant and a similar cut-off has previously been used in 
trials comparing surgery for different knee pathologies to 
non-operative treatment.10 14 39 To detect this difference, 
59 patients in each of the intervention groups is needed 
(assuming a common SD of 16.5, power=90%, alpha 
level=0.05). We plan to recruit a total of 140 patients to 
account for loss to follow-up (19%). Based on Danish 
National Patient Registry data from 2013 to 2014, more 
than a total of 800 primary meniscal procedures are 
carried out in patients aged 18–40 years at the partic-
ipating recruitment sites. Patients for the observational 
cohort will be included consecutively until inclusion in 
the RCT has been completed or until 1000 patients has 
been included.
stopping rule
If the intended sample size is not reached at 30 months 
after recruitment has started at all participating hospi-
tals, the inclusion of patients will stop at 106 patients, 
which will ensure a power of 80% anticipating 20% loss 
to follow-up.
statistical analysis
Between-group comparisons of change from baseline to 
1 year follow-up in the primary and secondary continuous 
outcomes (ie, KOOS, WOMET, muscle strength, knee-
bend test and jump performance) will be analysed using a 
repeated measures mixed model with patients as random 
effect, visit (baseline, 3, 6 and 12 months) and treatment 
arm (meniscal surgery or exercise and education) as fixed 
effects, and with adjustment for baseline imbalance and 
randomisation stratification factors, that is, hospital and 
gender. No imputation will take place. A CI excluding 10 
points or more in the KOOS4 score will be interpreted 
as a lack of a clinical meaningful difference. Differences 
in the trajectories of KOOS4 scores from baseline to 12 
months will be analysed using a random slopes and inter-
cepts model. The occurrence of adverse events will be 
compared between groups at the 1 year follow-up using a 
Poisson regression model with a robust error variance.40 
Categorical secondary outcomes will be analysed using Χ2 
test, Fisher's exact test or Mann-Whitney U test as appro-
priate.
All randomised patients will be included in the inten-
tion to treat analysis and in the safety analysis. Per 
protocol and as treated analyses will be performed for the 
primary outcome. Those who crossover to surgery or have 
poor compliance with the exercise in the exercise and 
education group and those who do not undergo surgery 
in the surgery group are excluded from the per protocol 
analysis, while the as-treated analysis is expected to have 
three groups, that is, including the group crossing over 
to surgery in addition to the original two randomisation 
groups.
A detailed statistical analysis plan will be made publicly 
available before unblinding the data and any analyses are 
performed.
EthIcs, dIssEMInAtIon And PErsPEctIvEs of thE study
Ethics and auditing
The study is approved by the Regional Committees 
on Health Research Ethics for Southern Denmark 
(S-20160151) and will be conducted in agreement with 
the Helsinki declaration. Informed consent material is 
available in Danish with the approved protocol. If a patient 
sustains any trial-related harm they are covered by Danish 
law. The Regional Committees on Health Research Ethics 
are annually selecting a number of studies for auditing. 
The audit process is independent of investigators and 
sponsors.
dissemination and protocol amendments
The primary RCT results will be submitted for publication 
to an international, peer-reviewed journal, regardless of 
whether the results are positive, negative or inconclusive 
in relation to the study hypothesis. Authorship eligibility 
will be based on the recommendations from the Inter-
national Committee of Medical Journal Editors (ICMJE).
Any important protocol amendments will be reported 
to the Regional Committees on Health Research Ethics 
for Southern Denmark, registered at  ClinicalTrials. gov 
and communicated in the primary RCT report.
Perspectives of the study
The results of this RCT will either provide high-quality 
evidence supporting a practice of early meniscal surgery 
for young adults aged 40 years or younger with meniscal 
tears or support a practice of initial supervised exercise 
therapy and patient education with the option of later 
surgery if needed in some patients. Either way, the results 
will provide scientific support for doctors and patients 
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when discussing the optimal treatment option for the 
individual patient.
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